Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Lieb

Showing results (11-20 of 319) with videos related to

Pageof 32
Sort By:
Current Psychiatry Reports|November 22, 2014
Pharmacotherapy for borderline personality disorder--current evidence and recent trendsJutta M Stoffers, Klaus Lieb
Lancet (London, England)|October 26, 2005
Deep brain stimulation for treatment of refractory depressionThomas E Schlaepfer, Klaus Lieb
The New England Journal of Medicine|November 25, 2006
Deep-brain stimulation for Parkinson's diseaseKlaus Lieb, Thomas E Schlaepfer
Journal of Clinical Psychopharmacology|January 19, 2002
Increased plasma concentration of maprotiline by coadministration of risperidoneClaus Normann, Klaus Lieb, Jörg Walden
Der Nervenarzt|November 9, 2006
[University privatization as a prospect or nightmare]Josef Aldenhoff, Jürgen Fritze, Klaus Lieb, et al.
Current Psychiatry Reports|January 24, 2004
New developments in the neurobiology of borderline personality disorderMartin Bohus, Christian Schmahl, Klaus Lieb
BMC Medical Ethics|March 11, 2014
Life context of pharmacological academic performance enhancement among university students--a qualitative approachElisabeth Hildt, Klaus Lieb, Andreas Günter Franke
The New England Journal of Medicine|April 16, 2002
Nonsteroidal drugs and Alzheimer's diseaseMichael Hüll, Klaus Lieb, Bernd L Fiebich
Neurochemistry International|November 8, 2002
Inhibition of LPS-induced iNOS and NO synthesis in primary rat microglial cellsKlaus Lieb, Stefanie Engels, Bernd L Fiebich
Expert Opinion on Pharmacotherapy|January 12, 2021
Is pharmacotherapy useful for treating personality disorders?Jutta Stoffers-Winterling, Birgit Völlm, Klaus Lieb
Pageof 32

Showing results (11-20 of 319) with videos related to

Sort By:
Pageof 32
Current Psychiatry Reports|November 22, 2014
Pharmacotherapy for borderline personality disorder--current evidence and recent trendsJutta M Stoffers, Klaus Lieb
Lancet (London, England)|October 26, 2005
Deep brain stimulation for treatment of refractory depressionThomas E Schlaepfer, Klaus Lieb
The New England Journal of Medicine|November 25, 2006
Deep-brain stimulation for Parkinson's diseaseKlaus Lieb, Thomas E Schlaepfer
Journal of Clinical Psychopharmacology|January 19, 2002
Increased plasma concentration of maprotiline by coadministration of risperidoneClaus Normann, Klaus Lieb, Jörg Walden
Der Nervenarzt|November 9, 2006
[University privatization as a prospect or nightmare]Josef Aldenhoff, Jürgen Fritze, Klaus Lieb, et al.
Current Psychiatry Reports|January 24, 2004
New developments in the neurobiology of borderline personality disorderMartin Bohus, Christian Schmahl, Klaus Lieb
BMC Medical Ethics|March 11, 2014
Life context of pharmacological academic performance enhancement among university students--a qualitative approachElisabeth Hildt, Klaus Lieb, Andreas Günter Franke
The New England Journal of Medicine|April 16, 2002
Nonsteroidal drugs and Alzheimer's diseaseMichael Hüll, Klaus Lieb, Bernd L Fiebich
Neurochemistry International|November 8, 2002
Inhibition of LPS-induced iNOS and NO synthesis in primary rat microglial cellsKlaus Lieb, Stefanie Engels, Bernd L Fiebich
Expert Opinion on Pharmacotherapy|January 12, 2021
Is pharmacotherapy useful for treating personality disorders?Jutta Stoffers-Winterling, Birgit Völlm, Klaus Lieb
Pageof 32